Floatz logo

Clostridium Novyi-Nt

Malignant Neoplasms of Urinary Tract

M.D. Anderson Cancer CenterCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Malignant Neoplasms of Urinary Tract cohort.

Asset / SponsorPhaseRating
Tas-102
M.D. Anderson Cancer Center
Phase 2CCC
Bms-907351
M.D. Anderson Cancer Center
Phase 2CCC
su011248
M.D. Anderson Cancer Center
Phase 2CCC
Epirubicin
M.D. Anderson Cancer Center
Phase 1CC
Pembrolizumab
M.D. Anderson Cancer Center
Phase 1CC

View all 10 →

Same molecule, other indications

Clostridium Novyi-Nt is also rated in:

digestive system cancerDormant
CC
Indicative ·
43 / 100
View asset →
Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous SystemDormant
CC
Indicative ·
43 / 100
View asset →
breast cancerDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →